Inflammation as Prognostic Hallmark of Clinical Outcome in Patients with SARS-CoV-2 Infection.

Bibliographic Details
Title: Inflammation as Prognostic Hallmark of Clinical Outcome in Patients with SARS-CoV-2 Infection.
Authors: Fuzio, Diana, Inchingolo, Angelo Michele, Ruggieri, Vitalba, Fasano, Massimo, Federico, Maria, Mandorino, Manuela, Dirienzo, Lavinia, Scacco, Salvatore, Rizzello, Alessandro, Delvecchio, Maurizio, Parise, Massimiliano, Rana, Roberto, Faccilongo, Nicola, Rapone, Biagio, Inchingolo, Francesco, Mancini, Antonio, Fatone, Maria Celeste, Gnoni, Antonio, Dipalma, Gianna, Dirienzo, Giovanni
Source: Life (2075-1729); Feb2023, Vol. 13 Issue 2, p322, 12p
Subject Terms: SARS-CoV-2, COVID-19, LYMPHOCYTE subsets, LYMPHOCYTE count
Abstract: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is often characterized by a life-threatening interstitial pneumonia requiring hospitalization. The aim of this retrospective cohort study is to identify hallmarks of in-hospital mortality in patients affected by Coronavirus Disease 19 (COVID-19). A total of 150 patients admitted for COVID-19 from March to June 2021 to "F. Perinei" Murgia Hospital in Altamura, Italy, were divided into survivors (n = 100) and non-survivors groups (n = 50). Blood counts, inflammation-related biomarkers and lymphocyte subsets were analyzed into two groups in the first 24 h after admission and compared by Student's t-test. A multivariable logistic analysis was performed to identify independent risk factors associated with in-hospital mortality. Total lymphocyte count and CD3+ and CD4+ CD8+ T lymphocyte subsets were significantly lower in non-survivors. Serum levels of interleukin-6 (IL-6), lactate dehydrogenase (LDH), C-reactive protein (CRP) and procalcitonin (PCT) were significantly higher in non-survivors. Age > 65 years and presence of comorbidities were identified as independent risk factors associated with in-hospital mortality, while IL-6 and LDH showed a borderline significance. According to our results, markers of inflammation and lymphocytopenia predict in-hospital mortality in COVID-19. [ABSTRACT FROM AUTHOR]
Copyright of Life (2075-1729) is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Complementary Index
Full text is not displayed to guests.
More Details
ISSN:20751729
DOI:10.3390/life13020322
Published in:Life (2075-1729)
Language:English